Caribou Biosciences (CRBU) Share-based Compensation Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - | -39.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.28% |
| Dec 31, 2025 | -29.99% |
| Sep 30, 2025 | -27.97% |
| Jun 30, 2025 | -33.96% |
| Mar 31, 2025 | -2.66% |
| Dec 31, 2024 | 9.98% |
| Sep 30, 2024 | 16.99% |
| Jun 30, 2024 | 32.16% |
| Mar 31, 2024 | 27.37% |
| Dec 31, 2023 | 14.67% |
| Sep 30, 2023 | 30.12% |
| Jun 30, 2023 | 22.86% |
| Mar 31, 2023 | 3.54% |
| Dec 31, 2022 | 96.51% |
| Sep 30, 2022 | 185.88% |
| Jun 30, 2022 | 392.07% |
| Mar 31, 2022 | 781.63% |
| Dec 31, 2021 | 583.12% |
| Sep 30, 2021 | 277.02% |
| Jun 30, 2021 | 107.34% |